Prolotherapy with 12.5% dextrose to treat temporomandibular joint dysfunction (TMD)
Crossref DOI link: https://doi.org/10.17352/2455-4634.000039
Published Online: 2019-04-17
Update policy: https://doi.org/10.17352/crossmark-policy
Ehab, Shehata
Version of Record valid from 2013-11-25
Accepted Manuscript valid from 2015-05-25